Sayiner M, Golabi P, Younossi ZM. Disease burden of hepatocellular carcinoma: a global perspective. Dig Dis Sci. 2019;64(4):910–7.
Article
CAS
PubMed
Google Scholar
Global Burden of Disease Liver Cancer C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver Cancer and underlying etiologies from 1990 to 2015 at the global, regional, and National Level: results from the global burden of disease study. JAMA Oncol 2017. 2015;3(12):1683–91.
Article
Google Scholar
Margini C, Dufour JF. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver Int. 2016;36(3):317–24.
Article
CAS
PubMed
Google Scholar
Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036.
CAS
PubMed
PubMed Central
Google Scholar
Marisi G, Cucchetti A, Ulivi P, Canale M, Cabibbo G, Solaini L, et al. Ten years of sorafenib in hepatocellular carcinoma: are there any predictive and/or prognostic markers? World J Gastroenterol. 2018;24(36):4152–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mendez-Blanco C, Fondevila F, Garcia-Palomo A, Gonzalez-Gallego J, Mauriz JL. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Exp Mol Med. 2018;50(10):1–9.
Article
CAS
PubMed
Google Scholar
Pastushenko I, Mauri F, Song Y, de Cock F, Meeusen B, Swedlund B, et al. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature. 2021;589(7842):448–55.
Article
CAS
PubMed
Google Scholar
Dong X, Fu J, Yin X, Cao S, Li X, Lin L, et al. Emodin: a review of its pharmacology, Toxicity and Pharmacokinetics. Phytother Res. 2016;30(8):1207–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim YS, Lee YM, Oh TI, Shin DH, Kim GH, Kan SY, et al. Emodin sensitizes hepatocellular carcinoma cells to the anti-Cancer effect of Sorafenib through suppression of cholesterol metabolism. Int J Mol Sci. 2018;19(10).
Hu N, Liu J, Xue X, Li Y: The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. Eur J Pharmacol 2020, 882:173269.
Shrimali D, Shanmugam MK, Kumar AP, Zhang J, Tan BK, Ahn KS, et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett. 2013;341(2):139–49.
Article
CAS
PubMed
Google Scholar
Brkanac SR, Geric M, Gajski G, Vujcic V, Garaj-Vrhovac V, Kremer D, et al. Toxicity and antioxidant capacity of Frangula alnus mill. Bark and its active component emodin. Regul Toxicol Pharmacol. 2015;73(3):923–9.
Article
CAS
PubMed
Google Scholar
Gu J, Cui CF, Yang L, Wang L, Jiang XH. Emodin inhibits Colon Cancer cell invasion and migration by suppressing epithelial-mesenchymal transition via the Wnt/beta-catenin pathway. Oncol Res. 2019;27(2):193–202.
Article
PubMed
PubMed Central
Google Scholar
Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, et al. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3. Br J Pharmacol. 2013;170(4):807–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen HT, Liu H, Mao MJ, Tan Y, Mo XQ, Meng XJ, et al. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer. 2019;18(1):101.
Article
PubMed
PubMed Central
Google Scholar
Vasaikar SV, Deshmukh AP, den Hollander P, Addanki S, Kuburich NA, Kudaravalli S, et al. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br J Cancer. 2021;124(1):259–69.
Article
CAS
PubMed
Google Scholar
Hung JH, Yang TH, Hu Z, Weng Z, DeLisi C. Gene set enrichment analysis: performance evaluation and usage guidelines. Brief Bioinform. 2012;13(3):281–91.
Article
PubMed
Google Scholar
Xu W, Yu M, Qin J, Luo Y, Zhong M. LACTB regulates PIK3R3 to promote autophagy and inhibit EMT and proliferation through the PI3K/AKT/mTOR signaling pathway in colorectal Cancer. Cancer Manag Res. 2020;12:5181–200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lorzadeh S, Kohan L, Ghavami S, Azarpira N. Autophagy and the Wnt signaling pathway: a focus on Wnt/beta-catenin signaling. Biochim Biophys Acta, Mol Cell Res. 2021;1868(3):118926.
Article
CAS
Google Scholar
Mancinelli R, Carpino G, Petrungaro S, Mammola CL, Tomaipitinca L, Filippini A, et al. Multifaceted roles of GSK-3 in Cancer and autophagy-related diseases. Oxidative Med Cell Longev. 2017;2017:4629495.
Article
CAS
Google Scholar
Liao X, Bu Y, Jia QG. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis. 2020;7(3):370–9.
Article
CAS
PubMed
Google Scholar
Chen SR, Qiu HC, Hu Y, Wang Y, Wang YT. Herbal medicine offered as an initiative therapeutic option for the Management of Hepatocellular Carcinoma. Phytother Res. 2016;30(6):863–77.
Article
PubMed
Google Scholar
Hu YY, Wang SP, Wu X, Zhang JM, Chen R, Chen MW, et al. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol. 2013;149(3):601–12.
Article
CAS
PubMed
Google Scholar
Yang K, Jin MJ, Quan ZS, Piao HR. Design and synthesis of novel anti-proliferative Emodin derivatives and studies on their cell cycle arrest, apoptosis pathway and migration. Molecules. 2019;24(5).
Zhou RS, Wang XW, Sun QF, Ye ZJ, Liu JW, Zhou DH, et al. Anticancer effects of Emodin on HepG2 cell: evidence from Bioinformatic analysis. Biomed Res Int. 2019;2019:3065818.
PubMed
PubMed Central
Google Scholar
Khan H, Jia WT, Yu Z, Zaib T, Feng J, Jiang YA, et al. Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2. Biomed Pharmacother. 2020;128.
Sun R, Zhai R, Ma C, Miao W. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway. Cancer Med. 2020;9(3):1141–51.
Article
CAS
PubMed
Google Scholar
Duan Y, Li J, Jing X, Ding X, Yu Y, Zhao Q. Fucoidan induces apoptosis and inhibits proliferation of hepatocellular carcinoma via the p38 MAPK/ERK and PI3K/Akt signal pathways. Cancer Manag Res. 2020;12:1713–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng G, Pi Z, Zhuang X, Zheng Z, Liu S, Liu Z, et al. The effects and mechanisms of aloe-emodin on reversing adriamycin-induced resistance of MCF-7/ADR cells. Phytother Res. 2021;35(7):3886–97.
Article
CAS
PubMed
Google Scholar
Dong XX, Ni BR, Fu J, Yin XB, You LT, Leng X, et al. Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase-dependent pathway. Oncol Rep. 2018;40(4):1985–93.
CAS
PubMed
PubMed Central
Google Scholar
Chihara T, Shimpo K, Beppu H, Yamamoto N, Kaneko T, Wakamatsu K, et al. Effects of Aloe-emodin and Emodin on proliferation of the MKN45 human gastric Cancer cell line. Asian Pac J Cancer Prev. 2015;16(9):3887–91.
Article
PubMed
Google Scholar
Liu JS, Huo CY, Cao HH, Fan CL, Hu JY, Deng LJ, et al. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine. 2019;61:152843.
Article
CAS
PubMed
Google Scholar
Zheng K, He ZD, Kitazato K, Wang YF. Selective autophagy regulates cell cycle in Cancer therapy. Theranostics. 2019;9(1):104–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghaznavi H, Shirvaliloo M, Zarebkohan A, Shams Z, Radnia F, Bahmanpour Z, et al. An updated review on implications of autophagy and apoptosis in tumorigenesis: possible alterations in autophagy through engineered nanomaterials and their importance in Cancer therapy. Mol Pharmacol. 2021;100(2):119–43.
Article
CAS
PubMed
Google Scholar
Yuan K, Xie K, Lan T, Xu L, Chen X, Li X, et al. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of beta-catenin. Cell Death Differ. 2020;27(4):1355–68.
Article
CAS
PubMed
Google Scholar
Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.
Article
PubMed
Google Scholar
Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, et al. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3beta/snail signaling. Cancer Sci. 2018;109(5):1414–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiao W, Miyazaki K, Kitajima Y. Inverse correlation between E-cadherin and snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer. 2002;86(1):98–101.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bugter JM, Fenderico N, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer. 2021;21(1):5–21.
Article
CAS
PubMed
Google Scholar
Santiago L, Daniels G, Wang DW, Deng FM, Lee P. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389–406.
CAS
PubMed
PubMed Central
Google Scholar
Liu R, Chen YW, Liu GZ, Li CX, Song YR, Cao ZW, et al. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11(9).
Xu Z, Han X, Ou D, Liu T, Li Z, Jiang G, et al. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104(2):575–87.
Article
CAS
PubMed
Google Scholar
Gorgulu K, Diakopoulos KN, Ai J, Schoeps B, Kabacaoglu D, Karpathaki AF, et al. Levels of the autophagy-related 5 protein affect progression and metastasis of pancreatic tumors in mice. Gastroenterology. 2019;156(1):203–217 e220.
Article
PubMed
CAS
Google Scholar
Kudo Y, Sugimoto M, Arias E, Kasashima H, Cordes T, Linares JF, et al. PKClambda/iota Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression. Cancer Cell. 2020;38(2):247–262 e211.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Xiong H, Liu D, Hill C, Ertay A, Li J, et al. Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells. Autophagy. 2019;15(5):886–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wei R, Xiao Y, Song Y, Yuan H, Luo J, Xu W. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis. J Exp Clin Cancer Res. 2019;38(1):112.
Article
PubMed
PubMed Central
Google Scholar
Tian Y, Wu J, Zeng L, Zhou L, Hu Y, Pan Q, et al. Huaier polysaccharides suppress triple-negative breast cancer metastasis and epithelial-mesenchymal transition by inducing autophagic degradation of snail. Cell Biosci. 2021;11(1):170.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lv Q, Hua F, Hu ZW. DEDD, a novel tumor repressor, reverses epithelial-mesenchymal transition by activating selective autophagy. Autophagy. 2012;8(11):1675–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zada S, Hwang JS, Ahmed M, Lai TH, Pham TM, Kim DR. Control of the epithelial-to-mesenchymal transition and Cancer metastasis by autophagy-dependent SNAI1 degradation. Cells. 2019;8(2).
Petherick KJ, Williams AC, Lane JD, Ordonez-Moran P, Huelsken J, Collard TJ, et al. Autolysosomal beta-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 2013;32(13):1903–16.
Article
CAS
PubMed
PubMed Central
Google Scholar